We are pleased to announce the addition of mymee to the Presenters at the Healthcare Investor Symposium this October in Las Vegas, NV. Chronic autoimmune disease impacts 24M Americans and costs $120B annually. Through a 12-week adaptive teletherapy program Mymee can reverse disease symptoms without expensive drugs, which have side effects like organ failure and death. Our health coaches identifying the patient-specific triggers and then create behavioral change to remove triggering behaviors and reverse symptoms. The Mymee program has been used with more than 125 patients and shows a 90% retention and a 75% disease reversal rate. This will save the US healthcare system billions of dollars by reducing the incidences of hospitalizations and drug use. Mymee is working to validate the intervention as a cost saving tool so that insurers will be happy to enter into shared savings contracts and provide it to the patients for free.
Learn more at mymee.com